AI-Driven Innovations in Translational Research: Accelerating Bench-to-Bedside Pipelines Through Predictive Modelling and Digital Biomarkers

Abstract

Artificial intelligence (AI) is revolutionising translational research by bridging the long-standing gaps between basic science and clinical practice. Traditional bench-to-bedside pipelines often suffer from inefficiencies in data integration, prolonged development timelines, and limited personalisation. This study investigates how AI-driven innovations, particularly predictive modelling and digital biomarkers, are reshaping translational workflows and enabling more responsive, efficient, and targeted biomedical interventions. The objective of this research is to critically explore the transformative impact of AI technologies in accelerating translational processes. A qualitative literature review was conducted, synthesising insights from peer-reviewed articles, clinical studies, and technical reports published over the past five years. Data collection focused on high-impact publications across biomedical informatics, clinical research, and AI applications in healthcare, identified through purposive sampling and refined via inclusion criteria aligned with translational relevance. Thematic analysis was employed to identify recurring patterns and strategies related to AI implementation. Key findings highlight that predictive modelling significantly enhances early-stage drug discovery, toxicity prediction, and clinical trial optimisation. Moreover, AI tools facilitate adaptive trial designs, improved patient recruitment, and automated data interpretation. Digital biomarkers—extracted from wearables, speech analysis, and physiological metrics—support continuous, non-invasive patient monitoring and disease progression tracking. These findings underscore that AI is not an auxiliary feature, but a core driver of translational efficiency and precision. The study concludes that embedding AI technologies into translational pipelines enhances accuracy, reduces timelines, and promotes scalable personalised medicine. Future research should focus on empirical validation, cross-sector interoperability, and ethical frameworks for responsible AI deployment in clinical research environments.

Ähnliche Arbeiten